Navigation Links
Years-Long Search Unlocks Deadly Genetic Disease
Date:1/10/2008

ttp://www.ninds.nih.gov/disorders/sma/sma.htm" target="_new">National Institutes of Health.



SOURCES: Lisa Baumbach-Reardon, Ph.D., associate research professor of pediatrics and neurology, University of Miami Miller School of Medicine; Ann Messer, Belton, Texas; E. Darrell Crisp, M.D., associate professor of internal medicine and pediatrics, Texas A&M Health Science Center College of Medicine, and director of pediatric neurology, Scott & White Hospital, College Station; Jan. 10, 2008, The American Journal of Human Genetics


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. New research demonstrates potential diagnosis, treatment benefits
2. NIST reference materials are gold standard for bio-nanotech research
3. DSS Research Announces Senior Health Risk Assessment Tool
4. Protein power: Researchers trigger insulin production in diabetic mice
5. Insights into cell movement likely to aid immune study, cancer research
6. American Association for Cancer Research hosts 2008 annual meeting
7. Vicky Goldberg Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay
8. UAB research could improve the prognosis and treatment of lung cancer
9. Beacon Research Issues TraderNotes on CERP, SEED, OSIR, GFRE, RIMM
10. Research Gets Closer to Origin of Parkinsons Disease
11. amfAR announces inaugural Mathilde Krim Fellowship Awards for AIDS research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Years-Long Search Unlocks Deadly Genetic Disease
Years-Long Search Unlocks Deadly Genetic Disease
(Date:7/25/2008)...swire/ -- Klafter & Olsen LLP has filed a,class ac...roCare" or the,"Company") (Nasdaq: ARTC ) and cer...r the Western District of Texas on behalf of all p...ArthroCare from January 24, 2008,through July 18, ...nd all,persons or entities who purchased call opti...
(Date:7/25/2008)... antiretroviral therapy may be due to genetic fact... -- A new study challenges the long-held belief th...system,s ability to restore itself after HIV patie...therapy (HAART). , From 50 percent to 90 percen...h HCV. Intravenous drug use is the main cause of b...
(Date:7/25/2008)...e/ -- BeaconEquity.com announces the,availability ...estors can view all of the daily trading notes for...oday,s Trade Alerts include: DUSA Pharmaceuticals ... Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA...(Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )....
(Date:7/25/2008)...n Significant Improvements in Members, Health, AT...leader in health,care quality management solutions...t has entered into a long-term agreement with Well...boration on Quality(SM) Incent and,Reward Best Pra...k and,primary care clinicians to promote improved ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...by Japanese government and produced by Unicef, the... Food and Agriculture// Organization, features Jac...untries and some colorful origami birds urging chi...In the advertisement shot in English at Sha Tin Ju...
...Britain and promoted by pop star Beyonce Knowles, ...ays.// All over the country, health shops are se...he shelves after pop star Beyonce Knowles said she... her latest film. The syrup, is said to be made ...
...desh to help malnourished children is yet to make ...led to aid the 5.7 million malnourished children o... age, Grassroots Features reported. Two-and-a-hal...riya tribal couple's daughter from Amolpath villag...
...iversity published his findings on a better substi...his month//. According to peer-reviewed research p...the kind of immune response doctors were looking f...ing, the vaccine was given to 100 volunteers at fo...
Other Medicine News:Health News:Scheme for Combating Malnourishment in MP Children Yet to Pick Up 2
(Date:7/22/2008)...a multi-center 293-patient European, trial -, h...ymbol: CYT, MONTREAL, July 22 /PRNewswire-FirstCa...ader in cryotherapy products to treat cardiac,arrh...resented from three,European study centers using t...ublished earlier today in the Journal of the Ameri...
(Date:7/22/2008)...s Development Initiative bring MJFF,s,current acti...nuary 20,2009, NEW YORK, July 22 /PRNewswire-USN...ry of transformative treatments and a cure for Par...r Parkinson,s Research has awarded,$2.7 million in... awards,were granted under MJFF,s Therapeutics Dev...
(Date:7/22/2008)...nd Efficacy of Treating Patients with ... and YONGIN-SI, South Korea, July 22 /PRNewswire/ ...ntario), and its South,Korean partner Green Cross ...Phase I clinical trial of its first-in-class lead ...ell-tolerated and resulted in clear,anti-cancer ef...
(Date:7/22/2008)... and Apidra(R) Resulted in Significant, Reductions... the Algorithm Us...sults from the "Adjust to,Target in Type 2 Diabete...e,Counting for Adjustment of Mealtime Insulin Glul...tes Association,s (ADA) medical journal,Diabetes ...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 1Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 3Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 5Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 6TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 1TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 2TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 3TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 4TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 5Private Equity Firms Acquire American Laser Centers 7939 1Private Equity Firms Acquire American Laser Centers 7939 2Brooks and the University of Florida Reach Research Agreement 7935 1Brooks and the University of Florida Reach Research Agreement 7935 2
...merican Academy of Neurology Annual Meeting,Show A...res, BOSTON, May 01, 2007 /PRNewswire/ -- Data fro...can Academy of Neurology (AAN),meeting suggest tha...ormulation of Lamictal(R) (lamotrigine) is effecti...ilepsy with and without,secondary generalization. ...
...omen published today shows reduction of 70,percent...s, EAST HANOVER, N.J., May 02, 2007 /PRNewswire/ -...c acid) Injection significantly,reduced the incide...er three years in women with postmenopausal osteop...land Journal of Medicine,marks the first time tha...
Other Medicine Technology:New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 2New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 3New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 4New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 2Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 3Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 4Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 6
Specially designed for rugged use; perfect tool with power and endurance. Balance of weight and power helps reduce user fatigue. Internally lubricated for longer serivce. Switch is designed and place
De Soutter supply clean cast removal saws that are low in voltage and contain an integrated extractor system, combining state-of-the-art ergonomics with performance and durability.
...he osteotomy staples is quite similar to the type ...e the inner position of the anti recoil contours a...lique staples). There are 3 kinds of staples: 1.... staples can have 3 different widths: 20mm, 26 mm ...
...e Barium Sulfate USP is specifically designed to p...pabilities for todays medical professionals who ad...y. Comprised of a uniform particle size, Biotrace ...lting in a consistent visualization of bone cement...
Medicine Products: